Literature DB >> 23121515

Screening for chronic comorbid diseases in people with HIV: the need for a strategic approach.

B Peters1, F Post, A S Wierzbicki, A Phillips, L Power, S Das, M Johnson, G Moyle, L Hughes, E Wilkins, E McCloskey, J Compston, E Di Angelantonio.   

Abstract

Among people living with HIV, the proportion of deaths attributed to chronic noninfectious comorbid diseases has increased over the past 15 years. This is partly a result of increased longevity in the era of highly active antiretroviral therapy (HAART), and also because HIV infection is related, causally or otherwise, to several chronic conditions. These comorbidities include conditions that are strongly associated with modifiable risk factors, such as cardiovascular disease (CVD), diabetes, and renal and bone diseases, and increasingly management guidelines for HIV recommend risk evaluation for these conditions. The uptake of these screening approaches is often limited by the resources required for their application, and hence the management of risk reduction in most HIV-infected populations falls below a reasonable standard. The situation is compounded by the fact that few risk calculators have been adjusted for specific use in HIV infection. There is substantial overlap of risk factors for the four common comorbid diseases listed above that are especially relevant in HIV infection, and this offers an opportunity to develop a simple screening approach that encompasses the key risk factors for lifestyle-related chronic disease in people with HIV infection. This would identify those patients who require more in-depth investigation, and facilitate a stepwise approach to targeted management. Such a tool could improve communication between patient and clinician. A significant proportion of people with HIV are sufficiently engaged with their care to participate in health promotion and take the lead in using patient-centric screening measures. Health-based social networking offers a mechanism for dissemination of such a tool and is able to embed educational messages and support within the process.
© 2012 British HIV Association.

Entities:  

Mesh:

Year:  2013        PMID: 23121515     DOI: 10.1111/j.1468-1293.2012.01055.x

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  14 in total

1.  Racial Disparities in Creatinine-based Kidney Function Estimates Among HIV-infected Adults.

Authors:  Naomi Anker; Rebecca Scherzer; Carmen Peralta; Neil Powe; Tanushree Banjeree; Michael Shlipak
Journal:  Ethn Dis       Date:  2016-04-21       Impact factor: 1.847

2.  Predicting diabetes risk among HIV-positive and HIV-negative women.

Authors:  Karla I Galaviz; Michael F Schneider; Phyllis C Tien; C Christina Mehta; Ighovwerha Ofotokun; Jonathan Colasanti; Vincent C Marconi; Kartika Palar; Gina Wingood; Adaora A Adimora; Maria Alcaide; Mardge H Cohen; Deborah Gustafson; Roksana Karim; Deborah Konkle-Parker; Daniel Merenstein; Anjali Sharma; Mohammed K Ali
Journal:  AIDS       Date:  2018-11-28       Impact factor: 4.177

3.  Chronic binge alcohol administration impairs glucose-insulin dynamics and decreases adiponectin in asymptomatic simian immunodeficiency virus-infected macaques.

Authors:  Stephen M Ford; Liz Simon; Curtis Vande Stouwe; Tim Allerton; Donald E Mercante; Lauri O Byerley; Jason P Dufour; Gregory J Bagby; Steve Nelson; Patricia E Molina
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-09-07       Impact factor: 3.619

4.  A cross-sectional randomised study of fracture risk in people with HIV infection in the probono 1 study.

Authors:  Barry S Peters; Melissa Perry; Anthony S Wierzbicki; Lisa E Wolber; Glen M Blake; Nishma Patel; Richard Hoile; Alastair Duncan; Ranjababu Kulasegaram; Frances M K Williams
Journal:  PLoS One       Date:  2013-10-29       Impact factor: 3.240

5.  Type 2 diabetes prevalence and its risk factors in HIV: A cross-sectional study.

Authors:  Alastair D Duncan; Louise M Goff; Barry S Peters
Journal:  PLoS One       Date:  2018-03-12       Impact factor: 3.240

6.  Myoblast mitochondrial respiration is decreased in chronic binge alcohol administered simian immunodeficiency virus-infected antiretroviral-treated rhesus macaques.

Authors:  Anthony A Duplanty; Robert W Siggins; Timothy Allerton; Liz Simon; Patricia E Molina
Journal:  Physiol Rep       Date:  2018-03

7.  Diagnosis and Management of HIV-Associated Pulmonary Diseases in a Ryan White-Funded Primary Care Setting.

Authors:  Kristin R V Harrington; Bashar S Staitieh; Minh Ly T Nguyen; Jonathan A Colasanti; Jieri Sumitani; Vincent C Marconi; Sara C Auld
Journal:  AIDS Patient Care STDS       Date:  2021-07       Impact factor: 5.944

Review 8.  HIV and Bone Disease: A Perspective of the Role of microRNAs in Bone Biology upon HIV Infection.

Authors:  Fabiola E Del Carpio-Cano; Raul A Dela Cadena; Bassel E Sawaya
Journal:  J Osteoporos       Date:  2013-10-27

9.  Factors associated with the frequency of monitoring of liver enzymes, renal function and lipid laboratory markers among individuals initiating combination antiretroviral therapy: a cohort study.

Authors:  Jennifer Gillis; Ahmed M Bayoumi; Ann N Burchell; Curtis Cooper; Marina B Klein; Mona Loutfy; Nima Machouf; Julio Sg Montaner; Chris Tsoukas; Robert S Hogg; Janet Raboud
Journal:  BMC Infect Dis       Date:  2015-10-26       Impact factor: 3.090

10.  Metabolic and Cardiovascular Comorbidities Among Clinically Stable HIV Patients on Long-Term ARV Therapy in Five Ambulatory Clinics in Lima-Callao, Peru.

Authors:  Jose A Hidalgo; Alberto Florez; Cecilia Agurto; Yvett Pinedo; Rosemarie Ayarza; Lourdes Rodriguez; Alberto La Rosa; Raul Gutierrez
Journal:  Open AIDS J       Date:  2018-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.